Freising, Germany

Uli Binder

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Uli Binder: Transforming Nucleic Acids and Polypeptides

Introduction

Uli Binder is a prominent inventor based in Freising, Germany, known for his significant contributions to the field of biotechnology. With a total of four patents to his name, Binder's work mainly focuses on the innovative uses of nucleic acids and polypeptides, particularly those rich in proline and alanine residues. His inventions are paving the way for advancements in pharmaceuticals and biological research.

Latest Patents

Binder's latest patents involve groundbreaking advancements in nucleic acids and biosynthetic polypeptides. One such invention describes nucleic acids encoding repetitive amino acid sequences that are low in repetitive nucleotide sequences. This invention highlights a nucleic acid molecule that comprises a low repetitive nucleotide sequence encoding a proline/alanine-rich amino acid repeat sequence, which forms a random coil. The encoded polypeptides can be utilized for creating biologically or pharmacologically active proteins and for drug conjugates.

Another notable patent focuses on biosynthetic proline/alanine random coil polypeptides, consisting of amino acid sequences solely made up of proline and alanine. This invention details methods for preparing these polypeptides and their potential applications in various biological contexts.

Career Highlights

Uli Binder has garnered experience and expertise from his tenure at notable institutions, including Xl-Protein GmbH and the Technische Universität München. His background in these organizations has equipped him with the skills necessary to push the boundaries of scientific understanding and innovation.

Collaborations

Throughout his career, Binder has had the opportunity to work alongside respected colleagues such as Arne Skerra and Martin Schlapschy. Their collaborative efforts have contributed to the advancement of research in the field and the successful development of Binder's innovative patents.

Conclusion

Uli Binder's work exemplifies the spirit of innovation within the scientific community. His contributions to nucleic acids and biosynthetic polypeptides are not only advancing research but also opening new avenues for therapeutic applications. With a strong foundation and collaboration with esteemed professionals, Binder is sure to continue making impactful discoveries in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…